Today: September 30, 2024
Today: September 30, 2024

Latest From Reuters

Health

Lilly CEO says weight-loss drug shortage to end 'very soon', Bloomberg News reports

U.S. drugmaker Eli Lilly expects its blockbuster weight-loss drug to officially come out of shortage in the United States in coming days, Bloomberg News reported on Thursday, citing an

Lilly CEO says weight-loss drug shortage to end 'very soon', Bloomberg News reports
Business|Finance|Health

Regeneron beats quarterly results on strong demand for eczema, eye treatments

Drugmaker Regeneron Pharmaceuticals exceeded estimates for second-quarter revenue and profit on Thursday, driven by strong demand for its top-selling eczema and eye drugs.

Regeneron beats quarterly results on strong demand for eczema, eye treatments
Business|Finance|Health

Labcorp beats Q2 profit and revenue estimates on demand for health tests

Labcorp beat Wall Street expectations for second-quarter profit and revenue on Thursday on strong demand for its diagnostic tests, and raised its sales growth forecast for the year.

Labcorp beats Q2 profit and revenue estimates on demand for health tests
Business|Finance|Health

Biogen lifts profit forecast, signals progress in turnaround effort

Biogen lifted its full-year profit forecast on Thursday due to cost cuts and better-than-expected sales of its various treatments, even as the U.S. adoption

Biogen lifts profit forecast, signals progress in turnaround effort
Asia|Business|Economy|Health

GE HealthCare cuts revenue growth forecast for 2024 on China woes

GE HealthCare cut its revenue growth forecast for the year on Wednesday, as a freeze in China's healthcare sector due to an anti-corruption drive dragged down sales of its imaging machines

GE HealthCare cuts revenue growth forecast for 2024 on China woes
Health

More than 80 patients evacuated from Gaza in biggest operation of war, WHO says

At least 85 sick and severely injured Palestinians from Gaza, including 35 children, were evacuated to Abu Dhabi for specialized care, the director general of the World Health

More than 80 patients evacuated from Gaza in biggest operation of war, WHO says
Business|Finance|Health

Dialysis firm FMC cuts outlook for US treatment volumes, shares fall

World's largest dialysis specialist Fresenius Medical Care cut the outlook for volumes in its key U.S. market on Tuesday after revenue from treatments there fell in the second quarter,

Dialysis firm FMC cuts outlook for US treatment volumes, shares fall
Europe|Health

Greece bans moving goats and sheep as 'goat plague' spreads

Greece has banned moving sheep and goats from their farms to try to contain a viral infection known as "goat plague" after new cases were detected over the weekend, the agriculture

Greece bans moving goats and sheep as 'goat plague' spreads
Business|Finance|Health

Abbott shares slide after trial verdict, weigh on rival Reckitt Benckiser

Abbott Laboratories' shares fell nearly 7% premarket, while British peer Reckitt Benckiser slumped 9% on Monday, after the U.S. healthcare firm was ordered to pay $495 million in damages

Abbott shares slide after trial verdict, weigh on rival Reckitt Benckiser
Business|Europe|Health|Stock Markets

Shares of Japan's Eisai tumble after EU rejects Alzheimer's drug

Shares of Japan's Eisai tumbled 11% and were on track for their biggest one-day fall in three years on Monday, after the European Union's regulator rejected the drugmaker's Leqembi

Shares of Japan's Eisai tumble after EU rejects Alzheimer's drug
Business|Europe|Health

Germany's Merck raises 2024 forecast on healthcare, electronics units' performance

Germany's Merck on Friday raised its forecast for the group, mainly driven by a strong operating performance at its healthcare and electronics units.

Germany's Merck raises 2024 forecast on healthcare, electronics units' performance
Europe|Health

EU regulator backs use of GSK's RSV shot in adults aged 50 to 59

The European Union health regulator on Friday recommended expanded use of GSK's respiratory syncytial virus (RSV) vaccine in adults aged between 50 and 59.

EU regulator backs use of GSK's RSV shot in adults aged 50 to 59
Business|Economy|Health

Indian drugmaker Cipla beats Q1 profit view on strong demand; shares hit record high

Cipla, India's third-largest generics drugmaker by sales, beat first-quarter profit estimates on Friday as it reported higher sales in its North

Indian drugmaker Cipla beats Q1 profit view on strong demand; shares hit record high
Celebrity|Entertainment|Health

Harvey Weinstein hospitalized again with COVID, other ailments

Jailed Hollywood producer Harvey Weinstein was moved to a New York hospital on Thursday with multiple ailments including COVID, his representatives said in a statement.

Harvey Weinstein hospitalized again with COVID, other ailments
Business|Finance|Health

Dexcom shares plunge after it cuts annual revenue forecast

Medical device maker Dexcom cut its annual revenue forecast on Thursday, blaming a restructuring of its sales team, fewer customers, and lower revenue from each customer, sending its

Dexcom shares plunge after it cuts annual revenue forecast
Europe|Health

EU regulator backs use of Novo's Wegovy to lower heart risks

The European Medicines Agency has backed the use of Novo Nordisk's Wegovy to lower major heart risks and strokes in overweight or obese adults without diabetes, the Danish drugmaker said on

EU regulator backs use of Novo's Wegovy to lower heart risks
Business|Finance|Health

AbbVie lifts 2024 profit forecast, shares hit record high

AbbVie increased its profit forecast for 2024 on Thursday after reporting strong sales of immunology drugs and quarterly results that exceeded Wall Street

AbbVie lifts 2024 profit forecast, shares hit record high
Business|Economy|Health

Swiss pharma firm Lonza's profit falls less than feared, shares rise

Swiss contract drug manufacturer Lonza reported a smaller-than-expected decline in first-half profit on Thursday, as a strong performance in its core

Swiss pharma firm Lonza's profit falls less than feared, shares rise
Business|Economy|Finance|Health

Sanofi lifts 2024 profit forecast on strength in Dupixent, new products

Sanofi on Thursday raised its full-year profit outlook after strong demand for blockbuster asthma drug Dupixent and better-than-expected sales of new launches helped its

Sanofi lifts 2024 profit forecast on strength in Dupixent, new products
Business|Finance|Health

Australia's Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement

Mayne Pharma has filed a lawsuit against India's Sun Pharma over infringements of patents related to a certain product used for menopause-related vaginal pain, the Australian drugmaker said

Australia's Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement
Health

UK regulator authorises updated Pfizer-BioNTech COVID shot targeting JN.1 strain

Britain's health regulator said on Wednesday it has authorised Pfizer and BioNTech's updated COVID-19 vaccine that targets the JN.1 subvariant for use in infants, children and adults.

UK regulator authorises updated Pfizer-BioNTech COVID shot targeting JN.1 strain
Business|Finance|Health

Thermo Fisher lifts profit forecast as biotech demand shows signs of improvement

Thermo Fisher on Wednesday raised its annual profit outlook and posted a better-than-expected second-quarter profit, banking on improved demand for its tools and services used in clinical

Thermo Fisher lifts profit forecast as biotech demand shows signs of improvement
Europe|Health

UN agencies urge Bosnia to vaccinate kids after two die in measles outbreak

The World Health Organization (WHO) and UNICEF on Tuesday urged Bosnia's authorities to raise the measles vaccination rate among children after two adolescents in the Balkan

UN agencies urge Bosnia to vaccinate kids after two die in measles outbreak
Europe|Health

Novo Nordisk's Wegovy gets UK approval for use to lower heart risks

Novo Nordisk's weight-loss drug Wegovy secured the UK regulator's approval for its use to reduce the risk of serious heart problems or strokes in overweight and obese adults, the agency

Novo Nordisk's Wegovy gets UK approval for use to lower heart risks
Economy|Health

England's health service facing unprecedented challenge, budget watchdog says

The National Health Service in England faces an unprecedented challenge from backlogs, workforce issues and rising demand, a budget watchdog said on Tuesday in a report outlining

England's health service facing unprecedented challenge, budget watchdog says

Follow